1,2,4-triazolo[4,3-a]pyridin-6-nitro, 3,8-dimethyl-, 97.0%, 10g

3-bromo-N-propylbenzamide, 95.0%, 1g

2-Bromo-3-nitrobenzaldehyde, 95.0%, 5g

1-Ethyl-2-fluoro-4-methoxy-5-nitrobenzene, 98.0%, 250mg

DROXINOSTAT, 98%, 100mg

Cloruro de plomo (II), mínimo 98 %, 100 g, envase de plástico.

Lámina de grafito de carbono 1,0 x 250 x 500 mm 1 ud

(4-((4-Ethylpiperazin-1-yl)sulfonyl)phenyl)boronic acid, 98%, 250mg

3-Bromo-6-chloropicolinonitrile, 95.0%, 1g

2-(2,4-Difluorophenoxy)-3-nitropyridine, 95.0%, 1g

methyl 2-amino-4-isopropylthiophene-3-carboxylate, 5g

1-Hydroxytetraphenylcylclopentadienyl(tetraphenyl-2,4-cyclopentadien-1-one)-mu-hydrotetracarbonyldiruthenium(II)100mg

boc-d-Threoninol(bzl), 97.0%, 1g